These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 751526

  • 1. Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
    Cristodorescu R, Gavrilescu S, Deutsch G, Berger E.
    Agressologie; 1978; 19(6):409-14. PubMed ID: 751526
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The influence of intravenous canrenoate on the determination of digoxin in serum by radio- and enzyme-immunoassay.
    Lichey J, Rietbrock N, Borner K.
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):61-3. PubMed ID: 370036
    [No Abstract] [Full Text] [Related]

  • 4. [Plasma-digoxin concentration in patients at time of hospital admission (author's transl)].
    Lichey J, Schröder R, Rietbrock N.
    Dtsch Med Wochenschr; 1977 Jul 22; 102(29):1056-60. PubMed ID: 891379
    [Abstract] [Full Text] [Related]

  • 5. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
    Nardoni A, di Piazza V, Moretti V, Copetti R, Trinco G, Geatti O.
    Clin Ter; 1988 May 31; 125(4):287-90. PubMed ID: 2974364
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of potassium-canrenoate on 3H-noradrenaline uptake and metabolism of the rat heart.
    Préda I, Sebeszta M, Harsányi A, Szabó G, Antalóczy Z.
    Acta Physiol Acad Sci Hung; 1978 May 31; 51(4):393-9. PubMed ID: 754480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spirolactones: clinical and pharmacologic studies.
    Corvol P, Claire M, Rafestin-Oblin ME, Michaud A, Roth-Meyer C, Menard J.
    Adv Nephrol Necker Hosp; 1977 May 31; 7():199-215. PubMed ID: 208407
    [No Abstract] [Full Text] [Related]

  • 11. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A, Tso G, Wells A.
    Ther Drug Monit; 2008 Dec 31; 30(6):744-7. PubMed ID: 18824952
    [Abstract] [Full Text] [Related]

  • 12. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A, Armbruster D, Petty D, Cooper KC, Dasgupta A.
    Ther Drug Monit; 2011 Feb 31; 33(1):128-31. PubMed ID: 21079546
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C, Mantellini R, Fanti P, Sciarra F.
    Minerva Med; 1983 Apr 07; 74(14-15):791-7. PubMed ID: 6339999
    [Abstract] [Full Text] [Related]

  • 15. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F, Ferraù O, Pitrone F, Luzza G, Russo A, Virga T.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract] [Full Text] [Related]

  • 16. [Action of spironolactone and potassium canrenoate].
    Zaun H.
    Hautarzt; 1990 Dec 30; 41(12):700. PubMed ID: 2089031
    [No Abstract] [Full Text] [Related]

  • 17. Selective stimulation of renal PGE2 by potassium canrenoate in essential hypertension.
    Castellani S, Scarti L, Masotti G, Del Rosso A, Chen JI, Neri Serneri GG.
    Prog Clin Biol Res; 1989 Dec 30; 301():297-301. PubMed ID: 2678128
    [No Abstract] [Full Text] [Related]

  • 18. Potassium prorenoate: a new steroidal aldosterone antagonist.
    Hofmann LM, Chinn LJ, Pedrera HA, Krupnick MI, Suleymanov OD.
    J Pharmacol Exp Ther; 1975 Aug 30; 194(2):450-6. PubMed ID: 1151770
    [Abstract] [Full Text] [Related]

  • 19. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A, Johnson MJ.
    J Clin Lab Anal; 2010 Aug 30; 24(6):413-7. PubMed ID: 21089173
    [Abstract] [Full Text] [Related]

  • 20. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 Aug 30; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.